Header image

Oral Abstracts - Concurrent 3: Understanding the Epidemics (Modelling/Surveillance)

Tracks
.
Thursday, August 10, 2017
2:00 PM - 3:30 PM
Tully Room I

Speaker

Dr Behzad Hajarizadeh
Associate Professor
Unsw / Kirby Institute

Incidence Of Hepatitis C Virus Infection In Two Maximum-Security Prisons In New South Wales, Australia: The Stop-C Study

2:00 PM - 2:15 PM

Abstract

Speaker Presentation

Biography

Dr Jenny Iversen
Senior Research Fellow
The Kirby Institute

Progress towards Elimination: Rapid Uptake of HCV Treatment among People Who Inject Drugs Following Broad Access to DAA Therapies

2:15 PM - 2:30 PM

Abstract

Biography

Dr Amy Kwon
Research Associate
Kirby Institute, UNSW Sydney

Australia Could Meet The WHO HCV Elimination Targets If The Current Rollout Of DAA Treatment Is Continued’

2:30 PM - 2:45 PM

Abstract

Speaker Presentation

Biography

Dr Nick Scott
Econometrician
Burnet Institute

Recommendations For Hepatitis C Virus Testing Among People Who Inject Drugs In Australia

2:45 PM - 3:00 PM

Abstract

Speaker Presentation

Biography

Dr Kelly Hosking
Director of Sexual Health Blood Borne Viruses
NT Health & Menzies School of Health Research

Tracking In Arnhem Land – On the Hunt for Hepatitis B Virus

3:00 PM - 3:15 PM

Abstract

Speaker Presentation

Biography

Ms Maryam Alavi
Research Associate
Kirby Institute, UNSW Sydney

Characterisation of Populations with Hepatitis C to Improve Access to Antiviral Therapy Programs: A Population-Based Linkage Study

3:15 PM - 3:20 PM

Abstract

Speaker Presentation

Biography

Dr Karen McCulloch
Research Fellow
University Of Melbourne

Updating Estimates Describing the Burden of Hepatitis B in Australia

3:20 PM - 3:30 PM

Abstract

Speaker Presentation

Biography


Chair

Rachel Sacks-Davis
Research Fellow
Burnet Institute

Linda Selvey
Associate Professor
School Of Public Health, The University Of Queensland





loading